Neurologists Encouraged to Use New Epilepsy Measures Published by AAN

March 18, 2011

Share:

The American Academy of Neurology has developed quality measures to help measure and improve the care of patients with epilepsy. These measures, developed by the AAN, were published in the January 4, 2011, edition of Neurology®.

The Epilepsy Quality Performance Measures are simple to implement and can easily improve epilepsy care. Most neurologists already follow many of the measures, so minor changes in practice are all that are required to meet the measures they are not following now. The measures assess performance with regard to:

  • Assessing frequency of each seizure type
  • Etiology evaluation
  • EEG assessment
  • MRI assessment
  • AED side effects
  • Refractory epilepsy consideration of referral for presurgical evaluation
  • Epilepsy related safety issues
  • Women's issues

Members are encouraged to use the measures in their practices. The epilepsy measures also will be incorporated into a NeuroPI℠ module for epilepsy, an AAN quality improvement tool that is designed to meet the Maintenance of Certification (MOC) Part IV PIP requirements mandated by the American Board of Psychiatry and Neurology (ABPN). This module will be released in the first quarter of 2011. Recently passed health care reform legislation contains provisions for 0.5 percent of Medicare billings in 2011 for clinicians who participate in maintenance of certification programs and also participate in the Physician Quality Reporting Initiative (PQRI) of the Centers for Medicare & Medicaid Services (CMS). Additionally, one does not have to be an ABPN diplomate or applying for MOC to participate. This effort by CMS to incentivize participation in MOC PIP improvement programs establishes a link between certification and payment.

Given these changes, quality measures development is an increasingly important initiative for specialty societies such as the AAN. The AAN recently introduced measures for Parkinson's disease, and is working on developing measures in stroke and stroke rehabilitation, dementia, neuropathy, headache, and multiple sclerosis. Members are encouraged to be involved by suggesting measure topic nominations to the Quality Measurement and Reporting Subcommittee.

Learn more

To learn more about the epilepsy measures or to get involved, contact Gina Gjorvad at ggjorvad@aan.com or (651) 695-2715.